help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Danadian, K.
Right arrow Articles by Arslanian, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Danadian, K.
Right arrow Articles by Arslanian, S.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 7 3022-3026
Copyright © 2001 by The Endocrine Society

Endocrine Care

Lipolysis in African-American Children: Is It a Metabolic Risk Factor Predisposing to Obesity?1

Kapriel Danadian, Vered Lewy, Janine J. Janosky and Silva Arslanian

Division of Pediatric Endocrinology, Metabolism and Diabetes Mellitus (K.D., V.L., S.A.), Children’s Hospital, University of Pittsburgh, Pittsburgh, Pennsylvania 15213; and Division of Biostatistics (J.J.J.), Department of Family Medicine and Clinical Epidemiology, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania 15213

Address all correspondence and requests for reprints to: Silva Arslanian, M.D., Division of Endocrinology, Children’s Hospital of Pittsburgh, 3705 Fifth Avenue, Pittsburgh, Pennsylvania 15213. E-mail: arslans{at}chplink.chp.edu

Abstract

Rates of obesity and type 2 diabetes are higher in African-American (AA), compared with American white (AW), adults and children. It is not known whether biologic and/or environmental differences are responsible for this racial disparity. We and others have demonstrated that AA children are hyperinsulinemic, compared with their AW peers. This investigation tested the hypothesis that hyperinsulinemia in AA children is associated with lower rates of lipolysis, which could be a risk factor for future obesity. Forty prepubertal children (20 AA and 20 AW) with comparable body composition (assessed by dual-energy x-ray absorptiometry) and visceral adiposity (evaluated with computed tomography scan) were studied. Total body lipolysis was measured with [2H5]glycerol after overnight fasting.

Basal lipolysis was approximately 40% lower in AA vs. AW children, whether the data were expressed for total body (85.7 ± 8.9 vs. 130.3 ± 14.1 µmol/min, P = 0.011) or per-kilogram BW (2.4 ± 0.2 vs. 3.8 ± 0.4 µmol/min·kg, P = 0.002) or per kilogram fat free mass (FFM) (3.3 ± 0.3 vs. 5.2 ± 0.5 µmol/min·kg FFM, P = 0.004), or per kg fat mass (FM) (13.7 ± 1.6 vs. 21.3 ± 3.3 µmol/min·kg FM, P = 0.046). Fasting insulin levels were higher in AA children (99.6 ± 7.8 vs. 77.4 ± 5.9 pmol/L, P = 0.032). Lipolysis correlated positively with fat mass, percent body fat, and abdominal fat mass. However, in multiple-regression analysis models after controlling for insulin and body composition, race remained a significant contributor to the variance in lipolysis.

In summary, the present study demonstrates that rates of lipolysis are significantly lower in AA children, compared with their white peers. This may constitute an early metabolic phenotype that may mediate fat trapping and susceptibility to obesity in a specific environmental context of energy excess conducive to fat accretion.

RATES OF OBESITY and type 2 diabetes are higher in African-Americans (AA), compared with American whites (AW) (1, 2, 3, 4). The onset of racial differences in obesity relates temporally to puberty, with prevalence of obesity increasing in blacks, relative to their white peers, during pubertal maturation (5, 6, 7, 8, 9). The underlying reason(s) for this racial disparity in obesity and diabetes remains open for investigation. It is not known whether biologic differences or environmental differences in diet and activity, together or independently, explain the observed racial difference in obesity and type 2 diabetes. We and others (10, 11, 12, 13) have demonstrated that AA children are hyperinsulinemic, compared with their AW peers. It is our hypothesis that this hyperinsulinemia inhibits lipolysis, leading, over time, to progressive fat accretion, in the presence of excess energy intake or diminished physical activity. Therefore, the aim of the current study was to investigate total body lipolysis in black vs. white prepubertal children to determine whether metabolic differences are discernible early in life that could explain the increased risk of obesity in blacks. Nonobese children were the target of investigation, to avoid clouding of the metabolic phenotype consequent to obesity (14, 15, 16, 17).

Subjects and Methods

Subjects

Twenty AA (10 males, 10 females) and 20 AW (10 males, 10 females) prepubertal children participated in the study. All studies were approved by the Human Rights Committee of Children’s Hospital of Pittsburgh. Study participants were recruited by newspaper advertisements in the community. The clinical characteristics of the study participants are summarized in Table 1Go. All subjects were documented to be in good health by history, physical examination, and routine hematological and biochemical tests. None were receiving any medication that may affect glucose and lipid metabolism. Pubertal development was assessed by careful physical examination according to the criteria of Tanner (18) and confirmed to be Tanner stage I by measurements of plasma testosterone in males, estradiol in females, and dehydroepiandrosterone-sulfate in both.


View this table:
[in this window]
[in a new window]
  		Table 1. Clinical characteristics, body composition, hormonal profile and fasting lipid concentrations of study subjects

 
Metabolic studies

All subjects were admitted to the General Clinical Research Center, on the previous afternoon, for testing on the morning after a 10–12 h overnight fast. Two iv catheters were inserted after the skin was anesthetized with Emla cream (Astra USA, Inc. Pharmaceutical Products, West Borough, MA). One was placed in a vein on the forearm for administration of [2H5]glycerol, and the second was placed in a vein on the dorsum of the contralateral heated hand for sampling of arterialized venous blood.

Total body lipolysis was measured at baseline, for 2 h, by the use of a prime (1.2 µmol/kg) constant rate (0.08 µmol kg-1 min-1) infusion of [2H5]glycerol (Isotec, Miamisburg, OH) described by us previously (19, 20). Blood was sampled at 0 min, at the start of the stable isotope infusion, and every 10 min, from 90–120 min, for determination of plasma glucose, insulin, FFA, glycerol, and isotopic enrichment of glycerol. Fasting blood was obtained for cholesterol, low-density lipoprotein, high-density lipoprotein, triglycerides, and very-low-density lipoprotein (VLDL) determination.

Continuous indirect calorimetry, by a ventilated hood system (Deltatrac metabolic monitor; Sensormedics, Anaheim, CA), was used to evaluate substrate oxidation, as described by us previously (11, 19, 20). Each evaluation was performed for a 30-min period at the end of the 2-h isotope infusion.

Body composition and abdominal adiposity

Body composition was assessed using dual-energy x-ray absorptiometry (21). Intraabdominal fat was measured by a 10-mm single axial computed tomography scan of the abdomen at the level of L4–5 lumbar vertebrae, as described by us before (21).

Biochemical measurements

Plasma glucose, insulin, FFA, and urinary nitrogen were measured according to our previously reported methods (10, 11, 19, 20). Serum glycerol was measured with a triglyceride kit (Sigma, St. Louis, MO). Plasma lipid levels were measured using the standards of the Centers for Disease Control and Prevention (22). Deuterium enrichment of glycerol in plasma was determined according to a modification of our previously described method (20). Plasma samples were deproteinized with methanol. The supernatant was dried in a vacuum centrifuge. The aldolnitrile pentacetate derivatives were formed by adding 40 µL pyridine:acetic anhydride (1:1 vol) and incubating for 30 min at 70 C. The sample was cooled, briefly centrifuged, and dried in a vacuum centrifuge to remove all of the pyridine. Before analysis, 50 µL ethyl acetate was added. All analyses were carried out on a 5971 mass spectrometer (Hewlett-Packard Co., Palo Alto, CA), in the electron impact mode, coupled to a Hewlett-Packard Co. 5890 Series II gas chromatograph. The data acquisition was in the selective ion monitoring mode for masses m/z 145 and 148 for unlabeled and labeled glycerol. Standard curves of known enrichments were performed with each assay.

Calculations

Total-body lipolysis was calculated from the rate of appearance of glycerol (Ra) in plasma according to steady-state tracer dilution equations (19, 20). Substrate oxidation rates were calculated from indirect calorimetric measurements according to the formulas of Frayn as described before (19, 20).

Statistical analysis

For continuous outcomes, between-group analyses (i.e. race or gender comparisons) were performed using ANOVA, in an attempt to control the experiment-wide {alpha}-rate. Data are presented as mean ± SE. P <= 0.05 was considered statistically significant. Multiple-regression analysis was applied to evaluate multivariate relationships.

Results

AA and AW children were comparable, in regards to age, puberty (Tanner stage I), body mass index (BMI), body composition, and visceral adiposity (Table 1Go). BMI percentiles, based on race and gender specific data (23), ranged from 15–90th percentile in whites and 10–90th percentile in blacks except for one boy, who was above the 95th percentile. Excluding the latter subject from analysis did not change the outcome of the results; therefore, his data were kept in the analysis. Fasting lipid concentrations were similar except for triglycerides and VLDL, which were significantly lower in black children (Table 1Go).

Metabolic data

There were no differences between AA and AW children in fasting glucose (5.1 ± 0.07 vs. 5.2 ± 0.06 mmol/L), FFA (277 ± 34 vs. 235 ± 23 µmol/L), and glycerol levels (74 ± 5 vs. 67 ± 4 µmol/L). Fasting insulin concentrations were higher in AA children (99.6 ± 7.8 vs. 77.4 ± 5.9 pmol/L, P = 0.032). Figure 1Go depicts that steady-state plasma isotopic enrichment was achieved during the last 30 min of [2H5]glycerol infusion. Rates of lipolysis after overnight fasting were lower in AA children, compared with AW children, whether the data were expressed for total body (85.7 ± 8.9 vs. 130.3 ± 14.1 µmol/min, P = 0.011) or per kg body weight (2.4 ± 0.2 vs. 3.8 ± 0.4 µmol/min·kg, P = 0.002) or per kg FFM (3.3 ± 0.3 vs. 5.2 ± 0.5 µmol/min·kg FFM, P = 0.004), or per kg fat mass (13.7 ± 1.6 vs. 21.3 ± 3.3 µmol/min·kg FM, P = 0.046) (Fig. 2Go). Rates of fat oxidation (2.9 ± 0.3 vs. 2.8 ± 0.3 µmol/kg·min) and glucose oxidation (21.0 ± 1.4 vs. 22.8 ± 1.8 µmol/kg·min) were similar between the two groups. When the results were analyzed separately for each gender, data remained consistent with the total group. Basal rates of lipolysis were lower in AA girls vs. AW girls (2.8 ± 0.2 vs. 4.1 ± 0.5 µmol/kg·min, P = 0.029) and in AA boys vs. AW boys (2.0 ± 0.3 vs. 3.6 ± 0.6 µmol/kg·min, P = 0.028).



View larger version (12K):
[in this window]
[in a new window]
  		Figure 1. Steady-state plasma isotopic enrichment of [2H5]glycerol during the last 30 min of the 2-h isotope infusion.

 


View larger version (21K):
[in this window]
[in a new window]
  		Figure 2. Basal lipolysis (glycerol, Ra) in black ({blacksquare}) and white children ({square}).

 
In all the subjects, lipolysis correlated with fat mass (r = 0.42, P = 0.007), percent body fat (r = 0.38, P = 0.014), visceral fat (r = 0.39, P = 0.015), and sc abdominal fat (r = 0.42, P = 0.008). These correlations were stronger in blacks (fat mass: r = 0.743, P = 0.005; percent body fat: r = 0.737, P = 0.005; visceral fat: r = 0.643, P = 0.002; and sc abdominal fat: r = 0.635, P = 0.003) than in whites (fat mass: r = 0.41, P = 0.077; percent body fat: r = 0.19, P = 0.4; visceral fat: r = 0.35, P = 0.15; sc abdominal fat: r = 0.45, P = 0.06). Fasting insulin concentrations were weakly correlated with rates of lipolysis (r = -0.295, P = 0.065). Multiple-regression models were done to investigate the differential race effects on the measures of lipolysis after controlling for measures of body composition and insulin. These models were generated for each of the measures of lipolysis separately (Table 2Go). Race was the significant variable contributing to the variance in rates of lipolysis.


View this table:
[in this window]
[in a new window]
  		Table 2. Multiple regression models

 
Discussion

The aim of the present study was to investigate whether it is possible to detect, early in childhood, biologic/metabolic markers that could potentially predispose black children to increased risk of obesity and type 2 diabetes. Our results demonstrate that AA children have approximately 40% lower rates of whole-body lipolysis, compared with their AW peers.

AA children are generally taller and heavier than Caucasian children of similar age (6, 8, 24, 25, 26), with a clear divergence in weight gain originating in late adolescence or early adulthood (6, 7, 8). Moreover, the disturbing increase in pediatric obesity and obesity-related type 2 diabetes in the United States is more pronounced in black children (4, 9, 27, 28). Differences in body fatness are believed to be the outcome of complex interactions among genetics, hormonal, and environmental influences that favor the net deposition of calories as fat (29). Based on previous observations of hyperinsulinemia in AA children (10, 11, 12, 13), we hypothesized that hyperinsulinemia, through inhibiting lipolysis, promotes fat accretion and thus may play a pathophysiological role in the excess risk of development of obesity in blacks. Our results show that whole-body lipolysis is significantly lower in prepubertal AA children, compared with AW children, but independent of hyperinsulinemia. This black/white contrast is unlikely to be attributable to differences in body composition, body fat topography, and fat cell size (14, 30, 31), because blacks and whites had comparable body composition parameters (Table 1Go). Also, in multiple-regression analysis, after controlling for these variables, race remained a significant contributor to the variance in lipolysis. Data are almost nonexistent, with respect to black/white differences in fat metabolism. Obese middle-age black women were reported to have increased glycerol release from sc adipose tissue, compared with white women (32); however, the black women were insulinopenic. In vitro adipocyte studies from black men showed higher epinephrine-stimulated lipolytic values, compared with white men (33). Comparison between the results of these studies and ours is not appropriate because of major differences in age, presence or absence of obesity, and local vs. in vitro vs. total body lipolysis. The lower rates of lipolysis could explain the significantly lower triglyceride and VLDL levels in black children in our study and in others (24, 34, 35). Despite lower rates of lipolysis in black children, rates of fat oxidation were similar to those of whites. Thus, it seems that black children burn fat more efficiently than whites. Whether or not this is a physiologic compensatory mechanism to protect against weight gain remains to be determined.

Lipolysis is exquisitely sensitive to the antilipolytic effect of insulin (14, 15, 17). In the present study, fasting insulin level was approximately 20% higher in black, compared with white, children. This is in agreement with other investigators’ findings of approximately 25% higher fasting insulin in black children (13). Contrary to our hypothesis, however, this hyperinsulinemia does not seem to explain the lower rates of lipolysis in blacks. It is possible though that blacks have increased fat cell sensitivity to the antilipolytic effect of insulin. This issue should be pursued further by performing stepwise insulin clamp experiments to generate insulin dose-response curves for suppression of lipolysis in blacks vs. whites. In this regard, it is interesting to note that a recent publication demonstrated that obese AA women, despite being resistant to insulin as a glucoregulatory hormone, were sensitive to insulin’s antilipolytic action (36). It remains to be investigated whether, in black children, there is differential sensitivity to the action of insulin on glucose vs. fat metabolism starting early in life.

Debate continues in the literature as to whether or not hyperinsulinemia is a result or a cause of obesity (37, 38). In 1962, the so-called thrifty genotype hypothesis was proposed by Neel (39). Fundamental to this theory is the hypothesis that hyperinsulinemia precedes obesity, with a differential in the insulin action on glucose vs. fat metabolism (40). The sum total of the antilipolytic effect of insulin would be increased, and mobilization of stored fat would be inhibited, i.e. lipid trapping. In 5- to 9-yr-old Pima Indian children who were followed longitudinally for approximately 10 yr, higher baseline fasting insulin concentration was associated with higher rates of weight gain and excess fat deposition in favor of the thrifty genotype (41). Furthermore, decreased rates of lipolysis in vitro were predictive of weight gain in nondiabetic Pima Indians (42). In agreement with the thrifty genotype theory, our results in AA children, a high-risk population for obesity and type 2 diabetes, demonstrate lower rates of lipolysis and higher levels of insulinemia. To our knowledge, the present study represents the first attempt to investigate black/white differences in rates of lipolysis early in childhood.

In summary, the present results suggest that nature may contribute to the increased risk of obesity in black children. Reduced rates of lipolysis in black normal children may constitute an early metabolic phenotype that may mediate fat trapping and susceptibility to obesity in a specific environmental context of energy surplus and hyperinsulinemia. It is intuitive that biologic risk markers be investigated at an early stage, before obesity sets in, because obesity-associated metabolic adaptations will overshadow the primary events ultimately leading to obesity. Longitudinal follow-up, however, is of utmost importance to investigate the future outcome of these biologic/metabolic markers and their relationship to weight gain.

Acknowledgments

We thank the nurses of the General Clinical Research Center, particularly Janet Bell and Amy Gilliland, for their expert nursing assistance; and Pat Antonio for secretarial assistance. These studies would not have been possible without the recruitment efforts of Lynnette Orlansky, the laboratory expertise of Resa Brna, and (most importantly) the commitment of the volunteer children and their parents.

Footnotes

1 This work was supported by grants from the Public Health Service [RO1-HD-27503 and MO1-RR-00084 (General Clinical Research Center)], Renziehausen Trust Fund, and a grant from Eli Lilly & Co. Presented at the 59th Annual Scientific Meeting of The American Diabetes Association, 1999. Back

Received August 25, 2000.

Revised December 28, 2000.

Accepted March 23, 2001.

References

  1. Cowie GC, Harris MI, Silverman RE, Johnson EW, Rust KF. 1993 Effect of multiple risk factors on differences between blacks and whites in the prevalence of noninsulin-dependent diabetes mellitus in the United States. Am J Epidemiol. 137:719–732.[Abstract/Free Full Text]
  2. Kumanyika S. 1993 Special issues regarding obesity in minority populations. Ann Intern Med. 119:650–654.[Abstract/Free Full Text]
  3. Williamson DF, Kahn HS, Ryers T. 1991 The 10-y incidence of obesity and major weight gain in black and white U.S. women aged 30–35 y. Am J Clin Nutr. 153:1515S–1518S.
  4. Arslanian S, Danadian K. 1998 Insulin secretion, insulin sensitivity and diabetes in Black children. Trends Endocrinol Metab. 9:194–199.[Medline]
  5. Melnyk MG, Weinstein E. 1994 Preventing obesity in black women by targeting adolescents: a literature review. J Am Diet Assoc. 94:536–540.[CrossRef][Medline]
  6. Morrison JA, Barton B, Biro FM, Sprecher DL, Falkner F, Obarzanek E. 1994 Sexual maturation and obesity in 9- and 10-year-old black and white girls: The National Heart, Lung and Blood Institute Growth and Health Study. J Pediatr. 124:889–895.[CrossRef][Medline]
  7. Burke GL, Savage PJ, Manolio TA, et al. 1992 Correlates of obesity in young Black and White women: The CARDIA Study. Am J Public Health. 82:1621–1625.[Abstract/Free Full Text]
  8. Must A, Dallal GE, Dietz WH. 1991 Reference data for obesity: 85th and 95th percentiles of body mass index (wt/ht2) and triceps skinfold thickness. Am J Clin Nutr. 53:839–846.[Abstract/Free Full Text]
  9. Troiano RP, Flegal KM, Kuczmasski RJ, Campbell SM, Johnson CL. 1995 Overweight prevalence and trends for children and adolescents. Arch Pediatr Adolesc Med. 149:1085–1091.[Abstract/Free Full Text]
  10. Arslanian S, Suprasongsin C. 1996 Differences in the in vivo insulin secretion and sensitivity in healthy black vs. white adolescents. J Pediatr. 129:440–443.[CrossRef][Medline]
  11. Arslanian S, Suprasongsin C, Janosky JE. 1997 Insulin secretion and sensitivity in Black versus White prepubertal healthy children. J Clin Endocrinol Metab. 82:1923–1927.[Abstract/Free Full Text]
  12. Svec F, Nastasi K, Hilton C, Bao W, Srinivasan SR, Berenson GS. 1992 Black-white contrasts in insulin levels during pubertal development: the Bogalusa Heart Study. Diabetes. 41:313–317.[Abstract]
  13. Gower BA, Nagy TR, Goran MI. 1999 Visceral fat, insulin sensitivity and lipids in prepubertal children. Diabetes. 48:1515–1521.[Abstract]
  14. Arner P. 1988 Control of lipolysis and its relevance to development of obesity in man. Diabetes Metab Rev. 4:507–515.[Medline]
  15. LeStunff C, Bougnères PF. 1992 Glycerol production and utilization during the early phase of human obesity. Diabetes. 41:444–450.[Abstract]
  16. LeStunff C, Bougnères P. 1994 Early changes in postprandial insulin secretion, not insulin sensitivity characterize juvenile obesity. Diabetes. 43:696–702.[Abstract]
  17. Robinson C, Tamborlane WV, Maggs DG, et al. 1998 Effect of insulin on glycerol production in obese adolescents. Am J Physiol. 274:E737–E743.
  18. Tanner JM. 1981 Growth and maturation during adolescence. Nutr Rev. 39:43–55.[Medline]
  19. Arslanian S, Kalhan SC. 1994 Correlations between fatty acid and glucose metabolism: potential explanation of insulin resistance of puberty. Diabetes. 43:908–914.[Abstract]
  20. Arslanian S, Suprasongsin C. 1997 Testosterone treatment in adolescents with delayed puberty: changes in body composition, protein, fat, and glucose metabolism. J Clin Endocrinol Metab. 82:3213–3220.[Abstract/Free Full Text]
  21. Danadian K, Balasekaran G, Lewy V, Meza MP, Robertson R, Arslanian SA. 1999 Insulin sensitivity in African-American children with and without family history of type 2 diabetes. Diabetes Care. 22:1325–1329.[Abstract]
  22. Matthews KA, Kuller LH, Wing RR, Meilann EN, Plantinga P. 1996 Prior use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol. 143:971–978.[Abstract/Free Full Text]
  23. Rosner B, Prineas R, Loggie J, Daniels SR. 1998 Percentiles for body mass index in U.S. children 5 to 17 years of age. J Pediatr. 132:211–222.[CrossRef][Medline]
  24. The National Heart, Lung, and Blood Institute Growth and Health Study Research Group. 1992 Obesity and cardiovascular disease risk factors in black and white girls: The NHLBI growth and health study. Am J Public Health. 82:1613–1620.[Abstract/Free Full Text]
  25. Owen GM, Lubin AH. 1973 Anthropometric differences between black and white preschool children. Am J Dis Child. 126:168–169.[Abstract/Free Full Text]
  26. Garn SM, Clark DC. 1975 Nutrition, growth, development, and maturation: findings from the Ten-State Nutrition Survey of 1968–1970. J Pediatr. 56:306–319.
  27. Gortmaker SL, Dietz WH, Sobol AM, Wehler CA. 1987 Increasing pediatric obesity in the United States. Am J Dis Child. 141:535–540.[Abstract/Free Full Text]
  28. Campaigne BN, Morrison JA, Schumann BC. 1994 Indexes of obesity and comparisons with previous national survey data in 9- and 10-year-old Black and White girls: The National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr. 124:675–678.[CrossRef][Medline]
  29. Rosenbaum M, Leibel RL, Hirsch J. 1997 Obesity. N Engl J Med. 337:396–407.[Free Full Text]
  30. Jensen MD. 1991 Regulation of forearm lipolysis in different types of obesity. In vivo evidence for adipocyte heterogeneity. J Clin Invest. 87:187–193.
  31. Hellmer J, Marcus C, Sonnenfeld T, Arner P. 1992 Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells. J Clin Endocrinol Metab. 75:15–20.[Abstract]
  32. van der Merwe MT, Crowther NJ, Schlaphoff GP, et al. 1998 Lactate and glycerol release from the subcutaneous adipose tissue of obese urban women from South Africa; important metabolic implications. J Clin Endocrinol Metab. 83:4084–4091.[Abstract/Free Full Text]
  33. Ama PFM, Poehlman ET, Simoneau JA, et al. 1986 Fat distribution and adipose tissue metabolism in non-obese male black African and Caucasian subjects. Int J Obes. 10:503–510.[Medline]
  34. Prewitt TE, Haynes SG, Graves K, Haines PS, Troler HA. 1988 Nutrient intake, lipids, and lipoprotein cholesterols in Black and White children: The Lipid Research Clinics Prevalence Study. Prev Med. 17:247–262.[CrossRef][Medline]
  35. Zoratti R. 1998 A review on ethnic differences in plasma triglycerides and high-density-lipoprotein cholesterol: is the lipid pattern the key factor for the low coronary heart disease rate in people of African origin. Eur J Epidemiol. 14:9–21.[CrossRef][Medline]
  36. Sumner AE, Kushner H, Sherif KD, Tulenko TN, Falkner B, Marsh JB. 1999 Sex differences in African-Americans regarding sensitivity to insulin’s glucoregulatory and antilipolytic actions. Diabetes Care. 22:71–77.[Abstract/Free Full Text]
  37. Ravussin E, Swinburn BA. 1996 Insulin resistance is a result, not a cause of obesity: Socratic debate—the pro side. In: Angel A, Anderson H, Bouchard C, Lau D, Leiter L, Mendelson R, eds. Progress in obesity research. 7th International Congress on Obesity. London: John Libbey & Company; 173–178.
  38. Sims EAH. 1996 Insulin resistance is a result, not a cause of obesity: Socratic debate—the con side. In: Angel A, Anderson H, Bouchard C, Lau D, Leiter L, Mendelson R, eds. Progress in obesity research. 7th International Congress on Obesity. London: John Libbey & Company; 587–592.
  39. Neel JV. 1962 Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress." Am J Hum Genet. 14:353–362.[Medline]
  40. Lev-Ran A. 1999 Thrifty genotype: how applicable is it to obesity and type 2 diabetes. Diabetes Rev. 7:1–22.
  41. Odeleye OE, de Courten M, Pettitt DJ, Ravussin E. 1997 Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children. Diabetes. 46:1341–1345.[Abstract]
  42. Snitker S, Foley JE, Ravussin E. 1998 Low in vitro adipocyte lipolysis predicts weight gain in non-diabetic Pima Indians. Diabetes. 47:A13.



This article has been cited by other articles:


Home page
 Diabetes CareHome page
S. Caprio, S. R. Daniels, A. Drewnowski, F. R. Kaufman, L. A. Palinkas, A. L. Rosenbloom, and J. B. Schwimmer
Influence of Race, Ethnicity, and Culture on Childhood Obesity: Implications for Prevention and Treatment: A consensus statement of Shaping America's Health and the Obesity Society
Diabetes Care, November 1, 2008; 31(11): 2211 - 2221.
[Full Text] [PDF]

Home page
 Diabetes and Vascular Disease ResearchHome page
C. O Nwobu and C. C Johnson
Targeting obesity to reduce the risk for type 2 diabetes and other co-morbidities in African American youth: a review of the literature and recommendations for prevention
Diabetes and Vascular Disease Research, December 1, 2007; 4(4): 311 - 319.
[Abstract] [PDF]

Home page
 Diabetes CareHome page
F. Bacha, R. Saad, N. Gungor, and S. A. Arslanian
Are Obesity-Related Metabolic Risk Factors Modulated by the Degree of Insulin Resistance in Adolescents?
Diabetes Care, July 1, 2006; 29(7): 1599 - 1604.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
Z. T. Bloomgarden
Second World Congress on the Insulin Resistance Syndrome: Mediators, pediatric insulin resistance, the polycystic ovary syndrome, and malignancy
Diabetes Care, July 1, 2005; 28(7): 1821 - 1830.
[Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
J Weill, S Vanderbecken, and P Froguel
Understanding the rising incidence of type 2 diabetes in adolescence
Arch. Dis. Child., June 1, 2004; 89(6): 502 - 504.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
Z. T. Bloomgarden
Type 2 Diabetes in the Young: The evolving epidemic
Diabetes Care, April 1, 2004; 27(4): 998 - 1010.
[Full Text] [PDF]

Home page
 DiabetesHome page
S. A. Arslanian, R. Saad, V. Lewy, K. Danadian, and J. Janosky
Hyperinsulinemia in African-American Children: Decreased Insulin Clearance and Increased Insulin Secretion and Its Relationship to Insulin Sensitivity
Diabetes, October 1, 2002; 51(10): 3014 - 3019.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
B. A. Gower, W. M. Granger, F. Franklin, R. M. Shewchuk, and M. I. Goran
Contribution of Insulin Secretion and Clearance to Glucose-Induced Insulin Concentration in African-American and Caucasian Children
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2218 - 2224.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Danadian, K.
Right arrow Articles by Arslanian, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Danadian, K.
Right arrow Articles by Arslanian, S.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals